(Q43561603)

24 November 2017

title

OPPIDUM surveillance program: 20 years of information on drug abuse in France (English)

1 reference

24 November 2017

1 reference

Elisabeth Frauger

1

1 reference

24 November 2017

Christophe Moracchini

2

1 reference

24 November 2017

Reynald Le Boisselier

3

1 reference

24 November 2017

David Braunstein

4

1 reference

24 November 2017

Xavier Thirion

5

1 reference

24 November 2017

Joëlle Micallef

6

1 reference

24 November 2017

French CEIPA-A Network

7

1 reference

24 November 2017

publication date

20 March 2013

1 reference

Fundamental and Clinical Pharmacology

24 November 2017

published in

1 reference

24 November 2017

volume

27

1 reference

24 November 2017

issue

6

1 reference

24 November 2017

page(s)

672-682

1 reference

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.

24 November 2017

cites work

1 reference

Prescription drug abuse: insight into the epidemic.

21 January 2018

1 reference

Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: an opportunity for cross-cultural comparisons

21 January 2018

1 reference

Guidelines and methodological reviews concerning drug abuse liability assessment

21 January 2018

1 reference

Principles of laboratory assessment of drug abuse liability and implications for clinical development

21 January 2018

1 reference

Principles of initial experimental drug abuse liability assessment in humans

21 January 2018

1 reference

ABC of mental health. Addiction and dependence--I: Illicit drugs

21 January 2018

1 reference

Introduction to College on Problems of Drug Dependence special conference on risk management and post-marketing surveillance of CNS drugs

21 January 2018

1 reference

Monitoring risk: post marketing surveillance and signal detection

21 January 2018

1 reference

Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys

21 January 2018

1 reference

Reasons for Drug Use among American Youth by Consumption Level, Gender, and Race/Ethnicity: 1976-2005

21 January 2018

1 reference

[First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development].

21 January 2018

1 reference

Recent evolution in opiate dependence in France during generalisation of maintenance treatments

21 January 2018

1 reference

Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey.

21 January 2018

1 reference

Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme

21 January 2018

1 reference

Comparison of methadone and high dosage buprenorphine users in French care centres

21 January 2018

1 reference

Neocodion misuse: evolution between 1992 and 2002

21 January 2018

1 reference

Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network

21 January 2018

1 reference

Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004

21 January 2018

1 reference

Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program

21 January 2018

1 reference

Why buprenorphine is so successful in treating opiate addiction in France

21 January 2018

1 reference

French field experience with buprenorphine

21 January 2018

1 reference

Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.

21 January 2018

1 reference

Chemical submission: results of 4-year French inquiry

21 January 2018

1 reference

Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network

21 January 2018

1 reference

Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse

21 January 2018

1 reference

The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?

21 January 2018

1 reference

Signal detection in post-marketing surveillance for controlled substances.

21 January 2018

1 reference

Potential for abuse of buprenorphine in office-based treatment of opioid dependence

21 January 2018

1 reference

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.

21 January 2018

1 reference

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey

21 January 2018

1 reference

Monitoring of benzodiazepine diversion using a multi-indicator approach

21 January 2018

1 reference

[General Practitioners' Contribution to Dependence Assessment: the OPEMA Programme].

21 January 2018

1 reference

A review of uses of health care utilization databases for epidemiologic research on therapeutics

21 January 2018

1 reference

Racial/ethnic differences in the relationship between parental education and substance use among U.S. 8th-, 10th-, and 12th-grade students: findings from the Monitoring the Future project

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/FCP.12024

1 reference

24 November 2017

1 reference